✦ LIBER ✦

Effect of Interferon-α in Patients with Chronic Myelogenous Leukemia in the Accelerated Phase: Cytogenetic and Molecular Studies

✍ Scribed by Ogura, Hiromi ;Tani, Kenzaburo ;Kozai, Yasuji ;Watari, Kiyoshi ;Kodo, Hideki ;Ozawa, Keiya ;Asano, Shigetaka ;Takaku, Fumimaro

Book ID: 108579111
Publisher: Wiley (Blackwell Publishing)
Year: 1990
Tongue: English
Weight: 304 KB
Volume: 81
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1990.tb02627.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simultaneous homoharringtonine and inter

Simultaneous homoharringtonine and interferon-α in the treatment of patients with chronic-phase chronic myelogenous leukemia

✍ Susan O'Brien; Moshe Talpaz; Jorge Cortes; Jianqin Shan; Francis J. Giles; Stefa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Long-term response in accelerated-phase

Long-term response in accelerated-phase chronic myelogenous leukemia with protracted splenic irradiation and ?-interferon

✍ Girinsky, T.; Bonomi, M.; Bayle, C. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 ± 4.6 Control 2 48.5 ± 14.1 Before chemotherapy 24.4 ± 6.2 b After chemotherapy 50.5 ± 6.5 Values are means ± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a patient with AILD-

Dysplastic basophils in the accelerated

Dysplastic basophils in the accelerated phase of chronic myelogenous leukemia

✍ Barbara J. Bain; Marc Heller 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Interferon alfa-2c in chronic myelogenou

Interferon alfa-2c in chronic myelogenous leukemia (CML): Hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma

✍ Herrmann, F. ;Jonas, D. ;Helfrich, S. G. ;Lindemann, A. ;Schleiermacher, E. ;Mer 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 849 KB

A phase II study alternating alpha-2a-in

A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia

✍ M. Talpaz; R. Kurzrock; H. Kantarjian; J. Rothberg; S. Saks; L. Evans; J. U. Gut 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

GM-CSF can improve the cytogenetic respo

GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia

✍ Cortes, J; Kantarjian, H; O’Brien, S; Kurzrock, R; Keating, M; Talpaz, M 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB